Leadership That Drives Clinical Excellence
Optimapharm is led by experienced industry professionals united by a passion for science, collaboration, and progress. Our executive and senior leadership teams, supported by respected strategic advisors, guide our mission to deliver smarter, faster, and more reliable clinical trials.
Executive Leadership
Ivana Waller
Chief Executive Officer
Miguel Salcedo
Chief Operating Officer
Mirna Šenjug Novak
Chief Financial Officer
Pavle Vukojevic
Chief Medical Officer
Paul Miller
Chief Commercial Officer
Senior Leadership
Karol Szczukiewicz
Executive Director, Project Management
Jan Schmejkal
Head of Operations, North America, and Executive Director, Project Management
Sara Weytjens
Vice President, Regulatory and Site Activation
Jelena Pavlović
Senior Director, Trial Support
Nataša Mihajlov
Executive Director, Clinical Operations
Lidia Almirall
Executive Director, Clinical Operations
Stiina Vuorio
Executive Director Clinical Operations
Vassil Vassilev
Biostatistics Director
Raivo Verk
Director, Data Management
Ivaylo Yordanov
Senior Director, Business Intelligence
Thurston King
Vice President, Commercial Operations
Ioustini Pollali
Director, FSP and Commercial Operations
Manigandan Murugaperumal
Senior IT Director
Sonja Ergić
Head of Legal and Corporate Services
Sanda Sudić Bušljeta
Vice President, People & Culture
Ivana Waller
Head of Quality Assurance
Supervisory Board
Colin Clark
Chairman
Stanislav Bachvarov
Vice-Chairman
Charles Woler
Igor Čičak
Stepan Karpukhin
Medical Advisors
Dr. Ignacio Garcia-Ribas
Medical Advisor
Dr. Siniša Radulović
Medical Advisor
Dr. Gail L. Brown
Medical Advisor
Fuentsanta Bellvis Bataller
Clinical Imaging
Dr. Martin Borovec
Medical Advisor
Dr. George Thornton
Medical Advisor
Dr. Mariam Pitava
Strategic Advisor
Dr. Robert Walsh
Medical Advisor
Dr. Gerald Klein
Medical Advisor
Mira Patel
Clinical Imaging
Dr. Katarina Andjelkov
Medical Advisor, Aesthetics
Dr. Roger E. Morgan, MD, FACS
Medical Advisor
Dr. Stephen Murray
Medical Advisor